tiprankstipranks
Bonus Biogroup (IL:BONS)
:BONS
Israel Market

Bonus Biogroup (BONS) Income Statement

Compare
1 Followers

Bonus Biogroup Income Statement

Last quarter (Q3 2024), Bonus Biogroup's total revenue was 0.00, a decrease of ― from the same quarter last year. In Q3, Bonus Biogroup's net income was -6.99M. See Bonus Biogroup’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
0.00 0.00 0.00 0.00 0.00
Gross Profit
0.00 -3.37M -4.10M -1.61M 0.00
Operating Expenses
29.82M 33.68M 60.64M 17.84M 20.91M
Depreciation and Amortization
1.65M 2.66M 1.48M 1.07M 1.08M
EBITDA
-28.14M -35.60M -67.05M -18.39M -20.03M
Operating Income
-29.79M -37.05M -64.73M -19.44M -20.91M
Other Income/Expenses
1.26M -1.66M -25.34M -2.58M -1.33M
Pretax Income
-28.53M -38.70M -90.08M -22.02M -22.24M
Net Income
-28.53M -38.70M -90.08M -22.02M -22.24M
Per Share Metrics
Basic EPS
-0.02 -0.06 -0.16 -0.06 -0.07
Diluted EPS
-0.02 -0.06 -0.16 -0.06 -0.07
Weighted Average Shares Outstanding
1.17B 621.08M 579.12M 393.93M 306.25M
Weighted Average Shares Outstanding (Diluted)
1.17B 621.08M 579.12M 393.93M 306.25M
Currency in ILS

Bonus Biogroup Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis